Article

May 2, 2012

William Lewis, MD, Addresses Ways to Improve the Patient-Physician Relationship

Dr. Lewis shares his thoughts on how the patient/provider relationship can be improved.

William Lewis, MD, states that by focusing on quality and shared decision making the patient/provider relationship can be improved in cardiology. Dr. Lewis also notes payment models currently being used in cardiology to provide patients with more cost-effective care and improved outcomes.

Related Videos

Jonathan Eisengart

Tiago Biachi, MD, PhD

Irina Dralyuk

Edgardo S. Santos, MD, FACP, FASCO

Irina Dralyuk

Keith Ferdinand, MD, professor of medicine and the Gerald S. Berenson Chair in Preventative Cardiology, Tulane University School of Medicine

Robin Glasco, Spencer Stuart

Edgardo S. Santos, MD, FACP, FASCO

Tiago Biachi, MD, PhD

Don M. Benson, MD, PhD, James Cancer Hospital

Related Content

Marie-France Jilderda, MD, PhD Candidate Surgical Oncology at Leiden University Medical Center in the Netherlands.

January 15th 2025

BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer

Cameron Santoro

The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.

Managed Care Cast

January 14th 2025

Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy

Giuliana Grossi

Jessica Tracy, head of Growth and Partnerships at Enthea, shares how employers and unions can support mental health and address access barriers to evidence-based ketamine treatments.

Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine

January 12th 2025

Designing Care for the Underserved Creates Higher-Value Health Solutions

In the second half of our interview with Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine, she discusses effective engagement of minoritized populations in discussion of medical mistrust.

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

Oscar B. Lahoud, MD, NYU Langone Health

January 7th 2025

Transparency in Drug Pricing Key to Reducing Patient Burden

Cochair of our recent Institute for Value-Based Medicine® event hosted with NYU Langone Health, Oscar B. Lahoud, MD, speaks on his hoped-for top health care priorities under the incoming administration.

Tim Mok, PharmD

January 4th 2025

Dr Tim Mok: A Pharmacist's Perspective on Balancing Costs and Outcomes

Tim Mok, PharmD, BCPS, BCOP, malignant hematology pharmacy research analyst at Kaiser Permanente, discussed his perspective on the balance between clinical outcomes and cost considerations.

Related Content

Marie-France Jilderda, MD, PhD Candidate Surgical Oncology at Leiden University Medical Center in the Netherlands.

January 15th 2025

BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer

Cameron Santoro

The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.

Managed Care Cast

January 14th 2025

Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy

Giuliana Grossi

Jessica Tracy, head of Growth and Partnerships at Enthea, shares how employers and unions can support mental health and address access barriers to evidence-based ketamine treatments.

Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine

January 12th 2025

Designing Care for the Underserved Creates Higher-Value Health Solutions

In the second half of our interview with Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine, she discusses effective engagement of minoritized populations in discussion of medical mistrust.

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

Oscar B. Lahoud, MD, NYU Langone Health

January 7th 2025

Transparency in Drug Pricing Key to Reducing Patient Burden

Cochair of our recent Institute for Value-Based Medicine® event hosted with NYU Langone Health, Oscar B. Lahoud, MD, speaks on his hoped-for top health care priorities under the incoming administration.

Tim Mok, PharmD

January 4th 2025

Dr Tim Mok: A Pharmacist's Perspective on Balancing Costs and Outcomes

Tim Mok, PharmD, BCPS, BCOP, malignant hematology pharmacy research analyst at Kaiser Permanente, discussed his perspective on the balance between clinical outcomes and cost considerations.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions